Moderna (MRNA) IV into COVID-19 vaccine boosters get FDA authorization

Moderna (NASDAQ: MRNA) 30-day option implied volatility is at 60; compared to its 52-week range of 51 to 131 into MRNA & Johnson & Johnson (JNJ) COVID-19 vaccine boosters get FDA authorization.

You May Also Be Interested In

• Uniti Group (UNIT) 3700 contracts of July 13 calls trade, share up 7%
• Southern Copper Corp. (SCCO) call put ratio 1.1 calls to 1.3 puts as share price up 3.4%
• Bristol-Myers Squibb (BMY) call put ratio 6.8 calls to 1 put with a focus on spreader of 8244 contracts of June and July 57.50 calls